Table 1.
Patient number | Sex | Current age (years) | Gene | Nucleotide position | Protein change | Mutation type | Zygosity | Pathogenecity |
|
---|---|---|---|---|---|---|---|---|---|
ACMG classification | |||||||||
1 | M | 13 | DSP | c.2131_2132delAG | p.Ser711CysfsX4 | Frameshift | Compound heterozygous | Pathogenic | |
c.7756C > T | p.Arg2586X | Nonsense | Pathogenic | ||||||
Group A | 2 | F | 9 | PKP2 | c.2577G > T | p.Lys859Asn | Missense | Homozygous | Likely pathogenic |
3 | M | 9 | DSP | c.250C > T | p.Arg84X | Nonsense | Heterozygous | Pathogenic | |
4 | M | 4 | JUP | c.2038_2039del | p.Trp680GlyfsX11 | Frameshift | Homozygous | Pathogenic | |
5 | M | 16 | PKP2 | c.2489 + 1 G > A | – | Splicing variant | Heterozygous | Pathogenic | |
Group B | 6 | M | 12 | DSG2 | c.1003A > G | p.Thr335Ala | Missense | Heterozygous | VUS |
7 | F | 18 | PKP2 | c.2146-1G > C | – | Splicing variant | Heterozygous | Pathogenic | |
8 | F | 12 | PKP2 | c.148_151delACAG | p.Thr50SerfsX61 | Frameshift | Heterozygous | Pathogenic | |
9 | M | 13 | PKP2 | c.148_151delACAG | p.Thr50SerfsX61 | Frameshift | Heterozygous | Pathogenic | |
10 | M | 16 | PKP2 | c.2146-1G > C | – | Splicing variant | Heterozygous | Pathogenic | |
Group C | 11 | F | 10 | DSP | c.1865 T > C | p.Leu622Pro | Missense | Heterozygous (de novo) | Likely pathogenic |
12 | F | 16 | – | – | – | – | – | – |